BioCryst names Charlie Gayer as next CEO after Jon Stonehouse retires
Go back to BioCryst names Charlie Gayer as next CEO after Jon Stonehouse retires| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 9.55 -0.11 (1.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.66 | 52 Week High | $10.98 | |||
| Open | $9.72 | 52 Week Low | $1.63 | |||
| Day High | $9.91 | P/E | N/A | |||
| Day Low | $9.48 | EPS | $-0.68 | |||
| Volume | 2,496,709 | |||||
